Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/1998
03/12/1998WO1998009970A2 Alkylated rapamycin derivatives
03/12/1998WO1998009965A1 NOVEL β-LACTAM COMPOUNDS AND PROCESS FOR PREPARING THE SAME
03/12/1998WO1998009961A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998WO1998009952A1 Methods of making hiv-protease inhibitors and intermediates for making them
03/12/1998WO1998009940A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
03/12/1998WO1998009938A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
03/12/1998WO1998009653A1 Association of no syntase inhibitors with trappers of oxygen reactive forms
03/12/1998WO1998009649A1 Inhibition of viral replication
03/12/1998WO1998009648A1 NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS
03/12/1998WO1998009647A2 Cyanidin compositions and therapeutic and diagnostic uses therefor
03/12/1998WO1998009646A1 A method for generating birnavirus from synthetic rna transcripts
03/12/1998WO1998009640A1 Antiviral treatment
03/12/1998WO1998009639A1 Novel bacteriocins, transport and vector system and method of use thereof
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998WO1998009599A2 The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
03/12/1998WO1998009533A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998WO1998009520A1 Antimicrobial compositions
03/12/1998WO1997046204A3 Injectable compositions
03/12/1998WO1997040854A3 Polypeptide conjugates for transporting substances across cell membranes
03/12/1998CA2795629A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998CA2266039A1 Alkylated rapamycin derivatives
03/12/1998CA2264926A1 Antiviral treatment
03/12/1998CA2264845A1 Novel bacteriocins, transport and vector system and method of use thereof
03/12/1998CA2264806A1 Novel .beta.-lactam compounds and process for preparing the same
03/12/1998CA2264798A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998CA2264737A1 Tetrahydronaphthalene derivatives and their therapeutic use
03/12/1998CA2264725A1 Methods of making hiv-protease inhibitors and intermediates for making them
03/12/1998CA2264654A1 1,3-dicarboxylic germanium complex and its therapeutic use
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists
03/12/1998CA2264486A1 Non-iga fc binding forms of the group b streptococcal beta antigens
03/12/1998CA2264286A1 Antimicrobial compositions
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998CA2263250A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
03/11/1998EP0827964A2 S-(+)-adenosylmethionine and 3'-azido-2',3'-dideoxy-nucleo-side complexes as potent inhibitors of HIV-replication
03/11/1998EP0827591A1 Method for diagnosing a patient for chlamydia
03/11/1998EP0827545A2 Retroviral vectors
03/11/1998EP0827514A1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
03/11/1998EP0827511A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
03/11/1998EP0827507A1 Protease inhibiting succinic acid derivatives
03/11/1998EP0827498A1 New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients
03/11/1998EP0827410A1 Method for introducing and expressing genes in animal cells
03/11/1998EP0827400A2 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
03/11/1998EP0677126B1 Antiviral topical pharmaceutical compositions
03/11/1998EP0663902B1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
03/11/1998EP0662946B1 Unsaturated aliphatic dicarboxylic acids
03/11/1998EP0656785B1 Method for inhibiting hiv replication using il-4
03/11/1998CN1175958A Monoclonal antiidiotypic antibodies (AB2) and uses thereof
03/11/1998CN1175955A Helicobacter pylori antigen
03/11/1998CN1175952A Clavulanic acid salts and method for preparing same
03/11/1998CN1175463A Anti-senility hypolipemic Chinese medicine liquor
03/11/1998CN1175427A Traditional Chinese medicine spray and ointment gauze for treatment of wound
03/11/1998CN1175411A Use of dicafeoyl quininic acid in treatment of hepatitis B and diseases associated with retrovirus and cafeoyl quininic acid derivs.
03/11/1998CN1037683C Triazolylthiomethylthio cephalosporin hydrochloride crystalline hydrate and production of same and its pharmaceutic composition
03/11/1998CN1037682C Process for preparing 2 -hydroxymethyl -5 -(5 -fluorocytosin -1 -yl) -1 ,3 -oxathiolane
03/11/1998CN1037680C Novel method of producing 7 -(substd.) -9 -£(substd. glycyl) -amino| -6 -demethyl 6 -deoxytetra -cylines
03/10/1998US5726312 Methods for preparing antiproliferative 5-substituted pyrimidone compounds
03/10/1998US5726205 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
03/10/1998US5726175 Imidazo 1,2-A!indeno 1,2-E!pyrazine-2-carboxylic acid derivatives, preparation thereof and drugs containing same
03/10/1998US5726170 Clavulanic acid salts
03/10/1998US5726151 Purified form of streptogramins, its preparation and pharmaceutical compositions containing it
03/10/1998US5725878 Pharmaceutical composition comprising HIV protease inhibiting compounds
03/10/1998US5725864 Contacting susceptible lymphoid cells with antiviral amount of iron-binding protein or derivative thereof
03/10/1998US5725862 Vaccine for branhamelia catarrhalis
03/10/1998US5725851 Method and compositions for treating injury
03/09/1998CA2214669A1 N-benzylazolium derivatives
03/05/1998WO1998008953A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998WO1998008952A1 Vaccine production of the bacillus anthracis protective antigen
03/05/1998WO1998008937A1 Method for sorting antifungal molecules acting on the glucanosyltransferase activity
03/05/1998WO1998008874A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008863A1 Enzyme and dna sequence encoding same
03/05/1998WO1998008856A2 Mirror-symmetrical selection and evolution of nucleic acids
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives
03/05/1998WO1998008829A1 Pharmaceutical compounds
03/05/1998WO1998008827A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998WO1998008542A2 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008509A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of aids
03/05/1998WO1998008508A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections
03/05/1998WO1998008375A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
03/05/1998WO1998001554A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1997033615A3 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
03/05/1998CA2265088A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998CA2264571A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
03/05/1998CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998CA2264297A1 Pharmaceutical compounds
03/05/1998CA2264244A1 Vaccine production of the bacillus anthracis protective antigen
03/05/1998CA2264045A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2264044A1 Spirocyclic metalloprotease inhibitors
03/05/1998CA2263932A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998CA2263885A1 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263499A1 Use of inhibitors of pkc for the manufacture of a medicament for the treatment of central nervous system diseases associated with hiv infection
03/05/1998CA2263161A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections
03/05/1998CA2263133A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of aids
1 ... 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 ... 1798